Finance

GUMING(01364.HK) will spend HKD 692.93 million to repurchase 34 million shares on Jun 24, 2026 - NewTimeSpace
GUMING(01364.HK) will spend HKD 692.93 million to repurchase 34 million shares on Jun 24, 2026

NewTimeSpace News: GUMING(01364.HK) will spend HKD 692.93 million to repurchase 34 million shares on Jun 24, 2026.

2026-06-25
GUMING01364.HKShare Repurchase
BRIGHT SMART(01428.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 670.25 million, YoY increase of 8.52% - NewTimeSpace
BRIGHT SMART(01428.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 670.25 million, YoY increase of 8.52%

NewTimeSpace News: June 24, 2026, BRIGHT SMART(01428.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 1.01 billion, increased by 3.7% YoY

2026-06-25
BRIGHT SMART01428.HKprofit
LAI GROUP(08455.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 9.46 million, loss narrowed by 27.21% YoY - NewTimeSpace
LAI GROUP(08455.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 9.46 million, loss narrowed by 27.21% YoY

NewTimeSpace News: June 24, 2026, LAI GROUP(08455.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 102.13 million, increased by 9.01% YoY

2026-06-25
LAI GROUP08455.HKloss narrowed
EXPERT SYS(08319.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 3.85 million, YoY decrease of 72.41% - NewTimeSpace
EXPERT SYS(08319.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 3.85 million, YoY decrease of 72.41%

NewTimeSpace News: June 24, 2026, EXPERT SYS(08319.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 999.81 million, increased by 11% YoY

2026-06-25
EXPERT SYS08319.HKfinancials
HK FINANCE GP(01273.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 70.13 million, YoY increase of 51.88% - NewTimeSpace
HK FINANCE GP(01273.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 70.13 million, YoY increase of 51.88%

NewTimeSpace News: June 24, 2026, HK FINANCE GP(01273.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 162.85 million, increased by 4.21% YoY

2026-06-25
HK FINANCE GP01273.HKprofit
MOBICON GROUP(01213.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 5.51 million, loss narrowed by 53.15% YoY - NewTimeSpace
MOBICON GROUP(01213.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 5.51 million, loss narrowed by 53.15% YoY

NewTimeSpace News: June 24, 2026, MOBICON GROUP(01213.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 271.12 million, decreased by 5.64% YoY

2026-06-25
MOBICON GROUP01213.HKloss narrowed
ULFERTS(01711.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 1.72 million, loss narrowed by 95.8% YoY - NewTimeSpace
ULFERTS(01711.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 1.72 million, loss narrowed by 95.8% YoY

NewTimeSpace News: June 24, 2026, ULFERTS(01711.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 137.17 million, decreased by 10.36% YoY

2026-06-25
ULFERTS01711.HKloss narrowed
DAZHONG DENTAL (02651.HK) plans to issue up to 1.2 million shares by placement, with estimated net proceeds of HKD 11.5 million - NewTimeSpace
DAZHONG DENTAL (02651.HK) plans to issue up to 1.2 million shares by placement, with estimated net proceeds of HKD 11.5 million

NewTimeSpace (newtimespace.com) News, DAZHONG DENTAL (02651.HK) plans to issue up to 1.2 million shares by placement, with estimated net proceeds of HKD 11.5 million.

2026-06-25
DAZHONG DENTAL02651.HKNewTimeSpace
Large Model Concept Stocks Watch | Zhipu (2513.HK) Rises Over 8% in Morning Trading; AI Investment and Demand Expected to Maintain High Prosperity - NewTimeSpace
Large Model Concept Stocks Watch | Zhipu (2513.HK) Rises Over 8% in Morning Trading; AI Investment and Demand Expected to Maintain High Prosperity

NewTimeSpace (newtimespace.com) News: On June 25, 2026, despite the weakening of the Hang Seng Tech Index, Hong Kong's artificial intelligence-themed stocks bucked the trend to strengthen. Zhipu (2513.HK) led the gains; as of 9:50 AM, the company's share price was quoted at HK$2,352.000, up 8.19%.

2026-06-25
NewTimeSpaceZhipu02513.HK
CHEN HSONG HOLD(00057.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 116.95 million, YoY decrease of 24.25% - NewTimeSpace
CHEN HSONG HOLD(00057.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 116.95 million, YoY decrease of 24.25%

NewTimeSpace (newtimespace.com) News, June 24, 2026, CHEN HSONG HOLD(00057.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 2.47 billion, decreased by 5% YoY

2026-06-25
CHEN HSONG HOLD00057.HKNewTimeSpace
RYKADAN CAPITAL(02288.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 143.62 million, loss narrowed by 48.96% YoY - NewTimeSpace
RYKADAN CAPITAL(02288.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 143.62 million, loss narrowed by 48.96% YoY

NewTimeSpace (newtimespace.com) News, June 24, 2026, RYKADAN CAPITAL(02288.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 51.39 million, decreased by 30.97% YoY

2026-06-25
RYKADAN CAPITAL02288.HKNewTimeSpace
PANGAEA CONNECT(01473.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 41.55 million, YoY increase of 36.15% - NewTimeSpace
PANGAEA CONNECT(01473.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 41.55 million, YoY increase of 36.15%

NewTimeSpace (newtimespace.com) News, June 24, 2026, PANGAEA CONNECT(01473.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 2.23 billion, increased by 4.77% YoY

2026-06-25
PANGAEA CONNECT01473.HKNewTimeSpace
GOLD PEAK(00040.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 32.59 million, YoY increase of 7.28% - NewTimeSpace
GOLD PEAK(00040.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 32.59 million, YoY increase of 7.28%

NewTimeSpace (newtimespace.com) News, June 24, 2026, GOLD PEAK(00040.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 7.02 billion, increased by 2.52% YoY

2026-06-25
GOLD PEAK00040.HKNewTimeSpace
KARRIE INT'L(01050.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 270.88 million, YoY increase of 32.47% - NewTimeSpace
KARRIE INT'L(01050.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 270.88 million, YoY increase of 32.47%

NewTimeSpace (newtimespace.com) News,June 24, 2026, KARRIE INT'L(01050.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 3.47 billion, increased by 7.37% YoY

2026-06-25
KARRIE INTL01050.HKNewTimeSpace
Phancy Group Co., Ltd.(06682.HK): Trustee Recently Purchases 700,000 H-Shares at an Average Price of Approximately HK$26.49 - NewTimeSpace
Phancy Group Co., Ltd.(06682.HK): Trustee Recently Purchases 700,000 H-Shares at an Average Price of Approximately HK$26.49

NewTimeSpace News: Phancy Group Co., Ltd. announced on June 24 that pursuant to its H-share Restricted Share Unit Scheme, the trustee acquired 700,000 H-shares on-exchange between June 22 and June 24, 2026, at an average price of HK$26.49 per share, with a total consideration of around HK$18.54 million.

2026-06-25
Phancy Group Co., Ltd.06682.HK
HUTCHMED (00013.HK): Key Phase II Data of Fisogatinib to Be Presented at ESMO Gastrointestinal Cancers Congress - NewTimeSpace
HUTCHMED (00013.HK): Key Phase II Data of Fisogatinib to Be Presented at ESMO Gastrointestinal Cancers Congress

NewTimeSpace News: HUTCHMED announced on June 25 that results from its pivotal Phase II registrational study of fisogatinib for the treatment of intrahepatic cholangiocarcinoma are set to be unveiled at the 2026 ESMO Gastrointestinal Cancers Congress.

2026-06-25
HUTCHMED00013.HK
Previous1..262263 264265266..361     361 pages total